Table 2.
Blood index of 102 patients with severe COVID-19.
| Index | Variable | Survival group (n = 73) |
Non-survival group (n = 29) |
P value |
|---|---|---|---|---|
| Blood routine | WBC (×10^9/L) | 4.92 [2.83] | 5.70 [0.49] | 0.226 |
| LYM (×10^9/L) | 0.66 [0.49] | 0.64 [0.44] | 0.694 | |
| PLT (×10^12/L) | 153 [66] | 113 [58] | 0.013 | |
| Liver function | ALT (U/L) | 26.0 [21.0] | 31.0 [33.0] | 0.169 |
| AST (U/L) | 32.0 [13.0] | 51.0 [50.0] | 0.000 | |
| ALB (U/L) | 37.55 ± 4.56 | 35.11 ± 6.05 | 0.115 | |
| TBIL (μmol/L) | 10.3 [5.7] | 12.2 [14.0] | 0.090 | |
| Renal function | BUN (μmol/L) | 4.2 [2.0] | 7.0 [4.4] | 0.000 |
| CR (μmol/L) | 58.4 [31.8] | 86.4 [25.5] | 0.004 | |
| Coagulation function | D-Dmer (μg/L) | 0.24 [0.29] | 0.57 [3.25] | 0.025 |
| PT (s) | 11.6 [1.2] | 12.4 [2.6] | 0.044 | |
| APTT (s) | 40.2 [7.1] | 40.7 [8.5] | 0.511 | |
| FIB (g/L) | 5.13 [1.63] | 4.22 [2.59] | 0.065 | |
| FVIII:C (%) | 2.50 [0.00] | 3.17 [29.8] | 0.003 | |
| Cardiac function | CK-MB (U/L) | 1.8 [1.8] | 7.2 [11.7] | 0.000 |
| CK (U/L) | 68 [74] | 327 [773] | 0.000 | |
| LDH (U/L) | 352.1 ± 140.91 | 785.47 ± 274.40 | 0.047 |